![]() |
Name |
Methyl geranate
|
Molecular Formula | C11H18O2 | |
IUPAC Name* |
methyl (2E)-3,7-dimethylocta-2,6-dienoate
|
|
SMILES |
CC(=CCC/C(=C/C(=O)OC)/C)C
|
|
InChI |
InChI=1S/C11H18O2/c1-9(2)6-5-7-10(3)8-11(12)13-4/h6,8H,5,7H2,1-4H3/b10-8+
|
|
InChIKey |
ACOBBFVLNKYODD-CSKARUKUSA-N
|
|
Synonyms |
Methyl geranate; 1189-09-9; methyl (2E)-3,7-dimethylocta-2,6-dienoate; methyl geraniate; 2,6-Octadienoic acid, 3,7-dimethyl-, methyl ester, (E)-; Methyl (E)-geranate; 2,6-Octadienoic acid, 3,7-dimethyl-, methyl ester; 26YR95MGP2; Geranic acid methyl ester; Methyl (E)-3,7-dimethylocta-2,6-dienoate; 2349-14-6; 2,6-Octadienoic acid, 3,7-dimethyl-, methyl ester, (2E)-; E-Methylgeranate; Methyl 3,7-dimethyl-2,6-octadienoate; Methyl-trans-geranate; UNII-26YR95MGP2; EINECS 214-712-6; Methyl trans-geranate; methyl-(E)-geranate; Methyl geranate AldrichCPR; 3,7-Dimethyl-2,6-octadienoic acid methyl ester; Methyl geranate, AldrichCPR; trans-Geranic acid methyl ester; methyl geranate, No Antioxidant; DTXSID40274147; CHEBI:166666; BAA18909; ZINC2003763; MFCD00036571; GERANIC ACID METHYL ESTER, TRANS-; CS-0453000; Q27254138; (2E)-3,7-dimethyl-octa-2,6-dienoic acid methyl ester; 2,6-OCTADIENOIC ACID, 3,7-DIMETHYL-, METHYL ESTER, TRANS-
|
|
CAS | 1189-09-9 | |
PubChem CID | 5365910 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 182.26 | ALogp: | 3.4 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 13 | QED Weighted: | 0.377 |
Caco-2 Permeability: | -4.4 | MDCK Permeability: | 0.00002500 |
Pgp-inhibitor: | 0.633 | Pgp-substrate: | 0.014 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.269 |
30% Bioavailability (F30%): | 0.143 |
Blood-Brain-Barrier Penetration (BBB): | 0.971 | Plasma Protein Binding (PPB): | 90.99% |
Volume Distribution (VD): | 2.856 | Fu: | 13.49% |
CYP1A2-inhibitor: | 0.926 | CYP1A2-substrate: | 0.727 |
CYP2C19-inhibitor: | 0.88 | CYP2C19-substrate: | 0.864 |
CYP2C9-inhibitor: | 0.716 | CYP2C9-substrate: | 0.74 |
CYP2D6-inhibitor: | 0.119 | CYP2D6-substrate: | 0.245 |
CYP3A4-inhibitor: | 0.15 | CYP3A4-substrate: | 0.28 |
Clearance (CL): | 8.027 | Half-life (T1/2): | 0.777 |
hERG Blockers: | 0.019 | Human Hepatotoxicity (H-HT): | 0.896 |
Drug-inuced Liver Injury (DILI): | 0.037 | AMES Toxicity: | 0.003 |
Rat Oral Acute Toxicity: | 0.011 | Maximum Recommended Daily Dose: | 0.042 |
Skin Sensitization: | 0.947 | Carcinogencity: | 0.074 |
Eye Corrosion: | 0.87 | Eye Irritation: | 0.921 |
Respiratory Toxicity: | 0.134 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001720 | ![]() |
1.000 | D09XWD | ![]() |
0.338 | ||
ENC001718 | ![]() |
0.579 | D0M1PQ | ![]() |
0.333 | ||
ENC001467 | ![]() |
0.543 | D05XQE | ![]() |
0.324 | ||
ENC001424 | ![]() |
0.537 | D0A7MY | ![]() |
0.277 | ||
ENC001434 | ![]() |
0.537 | D03VFL | ![]() |
0.258 | ||
ENC001649 | ![]() |
0.500 | D0Q6DX | ![]() |
0.237 | ||
ENC001717 | ![]() |
0.453 | D0Q9HF | ![]() |
0.229 | ||
ENC002413 | ![]() |
0.453 | D0OL6O | ![]() |
0.224 | ||
ENC001564 | ![]() |
0.451 | D0B1IP | ![]() |
0.209 | ||
ENC001664 | ![]() |
0.451 | D0X7XG | ![]() |
0.209 |